Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Characterization of PTPRG in knockdown and phosphatase-inactive mutant mice and substrate trapping analysis of PTPRG in mammalian cells.

Zhang W, Savelieva KV, Tran DT, Pogorelov VM, Cullinan EB, Baker KB, Platt KA, Hu S, Rajan I, Xu N, Lanthorn TH.

PLoS One. 2012;7(9):e45500. doi: 10.1371/journal.pone.0045500. Epub 2012 Sep 20.

2.

The role of anxiolytic premedication in reducing preoperative anxiety.

Carroll JK, Cullinan E, Clarke L, Davis NF.

Br J Nurs. 2012 Apr 26-May 9;21(8):479-83.

PMID:
22585076
3.

Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants.

Savelieva KV, Zhao S, Pogorelov VM, Rajan I, Yang Q, Cullinan E, Lanthorn TH.

PLoS One. 2008;3(10):e3301. doi: 10.1371/journal.pone.0003301. Epub 2008 Oct 15.

4.

Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.

Liu Q, Yang Q, Sun W, Vogel P, Heydorn W, Yu XQ, Hu Z, Yu W, Jonas B, Pineda R, Calderon-Gay V, Germann M, O'Neill E, Brommage R, Cullinan E, Platt K, Wilson A, Powell D, Sands A, Zambrowicz B, Shi ZC.

J Pharmacol Exp Ther. 2008 Apr;325(1):47-55. doi: 10.1124/jpet.107.132670. Epub 2008 Jan 11.

PMID:
18192499
5.

Effect of peritoneal fluid from women with endometriosis on implantation in the mouse model.

Illera MJ, Juan L, Stewart CL, Cullinan E, Ruman J, Lessey BA.

Fertil Steril. 2000 Jul;74(1):41-8.

PMID:
10899495
6.

Blockade of the alpha(v)beta(3) integrin adversely affects implantation in the mouse.

Illera MJ, Cullinan E, Gui Y, Yuan L, Beyler SA, Lessey BA.

Biol Reprod. 2000 May;62(5):1285-90.

PMID:
10775178
7.

IL-1 receptor accessory protein is an essential component of the IL-1 receptor.

Cullinan EB, Kwee L, Nunes P, Shuster DJ, Ju G, McIntyre KW, Chizzonite RA, Labow MA.

J Immunol. 1998 Nov 15;161(10):5614-20.

8.

Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice.

Labow M, Shuster D, Zetterstrom M, Nunes P, Terry R, Cullinan EB, Bartfai T, Solorzano C, Moldawer LL, Chizzonite R, McIntyre KW.

J Immunol. 1997 Sep 1;159(5):2452-61.

PMID:
9278338
9.
10.

Transcription factor mTEAD-2 is selectively expressed at the beginning of zygotic gene expression in the mouse.

Kaneko KJ, Cullinan EB, Latham KE, DePamphilis ML.

Development. 1997 May;124(10):1963-73.

11.

Preimplantation development of the mammalian embryo and its regulation by growth factors.

Stewart CL, Cullinan EB.

Dev Genet. 1997;21(1):91-101. Review.

PMID:
9291585
12.

Reproduction in mice lacking a functional type 1 IL-1 receptor.

Abbondanzo SJ, Cullinan EB, McIntyre K, Labow MA, Stewart CL.

Endocrinology. 1996 Aug;137(8):3598-601.

PMID:
8754793
13.

Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation.

Cullinan EB, Abbondanzo SJ, Anderson PS, Pollard JW, Lessey BA, Stewart CL.

Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3115-20.

14.

[Regulation by maternally derived cytokines of pre-implantation development and uterine receptiveness].

Stewart CL, Abbondanzo SJ, Cullinan EB.

Contracept Fertil Sex. 1995 Sep;23(9):555-61. Review. French.

PMID:
7496429
15.

LIF and related cytokines in the regulation of mammalian development.

Stewart CL, Cullinan E.

Ann N Y Acad Sci. 1995 Jul 21;762:29-30. No abstract available.

PMID:
7668532
16.

Notes to newcomers.

Cullinan EA.

J Assoc Healthc Philanthr. 1992 Spring:43-4. No abstract available.

PMID:
10124269
17.

Extrachromosomal chromatin: novel target for bleomycin cleavage in cells and solid tumors.

Cullinan EB, Gawron LS, Rustum YM, Beerman TA.

Biochemistry. 1991 Mar 26;30(12):3055-61.

PMID:
1706627
18.

Topoisomerase II-mediated DNA damage of episomes in tumor-bearing mice.

Cullinan EB, Gawron LS, Rustum YM, Beerman TA.

Cancer Res. 1990 Oct 1;50(19):6154-7.

19.

A study of drug-induced topoisomerase II-mediated DNA lesions on episomal chromatin.

Cullinan EB, Beerman TA.

J Biol Chem. 1989 Sep 25;264(27):16268-75.

20.

Neocarzinostatin and auromomycin preferentially cleave simian virus 40 DNA and chromosomes at a number of discrete locations.

Grimwade JE, Cullinan EB, Beerman TA.

Biochim Biophys Acta. 1988 Jul 13;950(2):102-12.

PMID:
2838085
21.

Advances in medicine.

CULLINAN E.

Practitioner. 1962 Oct;189:405-15. No abstract available.

PMID:
14024207
22.

Trends in medicine 1939-1958.

CULLINAN ER.

Trans Med Soc Lond. 1959;75:1-14. No abstract available.

PMID:
13813248
23.

The prognosis of infective hepatitis; a preliminary account of a long-term follow-up.

CULLINAN ER, KING RC, RIVERS JS.

Br Med J. 1958 Jun 7;1(5083):1315-7. No abstract available.

24.

The treatment of ulcerative colitis.

CULLINAN ER, MACDOUGALL IP.

Practitioner. 1957 Nov;179(1073):549-60. No abstract available.

PMID:
13484674
25.

The clinical pattern and prognosis of infective hepatitis.

CULLINAN ER.

Br Med Bull. 1957 May;13(2):126-8. No abstract available.

PMID:
13426538
26.

The natural history of ulcerative colitis.

CULLINAN ER, MACDOUGALL IP.

Lancet. 1957 Mar 9;272(6967):487-9. English, French. No abstract available.

PMID:
13407043
27.

Infektiƶse Hepatitis.

CULLINAN ER.

Dtsch Med Wochenschr. 1957 Feb 15;82(7):237-43. German. No abstract available.

PMID:
13427482
28.

Polyarteritis nodosa.

CULLINAN ER, KING RC.

Proc R Soc Med. 1956 Nov;49(11):934-5. No abstract available.

29.

The natural history of ulcerative colitis.

CULLINAN ER, MACDOUGALL IP.

Gastroenterologia. 1956;86(5):582-90. No abstract available.

PMID:
13405119
30.

Diffuse systemic sclerosis.

CULLINAN ER.

Acta Med Scand Suppl. 1956;312:465-6. No abstract available.

PMID:
13339224
31.

Surgical indications in portal hypertension.

CULLINAN ER.

Proc R Soc Med. 1954 Jun;47(6):478-80. No abstract available.

32.

Scleroderma (diffuse systemic sclerosis).

CULLINAN ER.

Proc R Soc Med. 1953 Jul;46(7):507-11. No abstract available.

33.

Some disorders of the liver and bile passages.

CULLINAN ER.

Trans Med Soc Lond. 1953;69:115-63. No abstract available.

PMID:
13146791
34.

Discussion on chronic diarrhoea, excluding tropical causes.

CULLINAN ER, GILL AM, PAULLEY JW.

Proc R Soc Med. 1949 Apr;42(4):235-44. No abstract available.

35.

Medical disorders in East Africa.

CULLINAN ER.

Trans R Soc Trop Med Hyg. 1946 Apr;39:353-72. No abstract available.

PMID:
21028604
36.

Description of an outbreak of beriberi; with special reference to the aetiology of beriberi and epidemic dropsy.

CULLINAN ER, KEKWICK A, et al.

Q J Med. 1946 Apr;15:91-105. No abstract available.

PMID:
20988937
37.

Immunity to sandfly fever.

CULLINAN ER.

Br Med J. 1946 Jan 5;1:12. No abstract available.

PMID:
21008535
38.

Immunity to Sandfly Fever.

Cullinan ER.

Br Med J. 1946 Jan 5;1(4435):12. No abstract available.

39.

Sandfly Fever in the Middle East.

Cullinan ER, Whittaker SR.

Br Med J. 1943 Oct 30;2(4321):543-5. No abstract available.

40.

The Epidemiology of Jaundice: (Section of Epidemiology and State Medicine).

Cullinan ER.

Proc R Soc Med. 1939 Jun;32(8):933-50. No abstract available.

41.

Recurrent Attacks of Acute Pancreatic Dysfunction with Spontaneous Recovery: (Section of Surgery).

Cullinan ER, Stewart JG.

Proc R Soc Med. 1939 Apr;32(6):681-4. No abstract available.

42.

Ulcerative Colitis: Clinical Aspects.

Cullinan ER.

Br Med J. 1938 Dec 31;2(4069):1351-6. No abstract available.

43.

The Prevention and Treatment of Infections by Specific Immune Therapy.

Cullinan ER.

Postgrad Med J. 1934 Jul;10(105):247-54. No abstract available.

44.

Dermatomyositis.

Cullinan ER.

Proc R Soc Med. 1932 Aug;25(10):1522-8. No abstract available.

Supplemental Content

Loading ...
Support Center